Biovitrum listed on the Nordic Exchange in Stockholm
Today, Biovitrum AB has been listed on the O list of the Stockholm Stock Exchange. Biovitrum is the fifty-third company to join the Nordic Exchange this year.Biovitrum AB is a biopharma company with operations in Sweden and in the UK. The company conducts research and develops pharmaceuticals for the treatment of obesity, diabetes, inflammation and blood diseases. Biovitrum also develops and produces protein-based drugs on a contractual basis and markets a range of specialist pharmaceuticals primarily in the Nordic countries. Biovitrum has a turnover of approximately SEK 1 billion and some